Patients diagnosed with metastatic breast cancer often face persistent pain before, during, and after their treatment. Understanding the nature of this pain, its causes, and potential management strategies is crucial for improving the quality of life for those affected by the illness.
:max_bytes(150000):strip_icc():format(jpeg)/Person-walking-cecd2868dea745be893650a92e47b9cf.jpg)
Christina Thammasen, now 41, discovered a lump in her breast while breastfeeding her third child at the age of 33. Initially, the lump was small and painless. However, as weeks passed, it grew and became painful. After a biopsy, Thammasen was diagnosed with stage 4 HER2-positive breast cancer, a type characterised by the rapid growth of cancer cells due to increased HER2 protein levels. Within a month of her diagnosis, she commenced weekly chemotherapy, a treatment regimen that has evolved over the years. Today, she receives chemotherapy every three weeks, coupled with scans every six months.


Despite a shift in her treatment approach, Thammasen continues to cope with persistent physical pain. She describes her pain as an all-encompassing, chronic issue stemming from her nearly nine years of continuous treatment. “Over time, one thing that hurts can cause pain in another area of your body,” she explains, remarking on the cumulative side effects of prolonged therapy.
The occurrence of pain is not uncommon among breast cancer patients, with research indicating that approximately two-thirds of individuals with metastatic breast cancer experience significant discomfort. Such pain can be attributed to various factors, including the type of cancer, the extent of its progression, and the treatments administered. While not all breast cancer patients endure physical pain, those who do must navigate a complex landscape of symptom management.
A significant cause of pain in these patients can be traced to bone metastasis, wherein cancer cells migrate to the bone and compromise its structure. This migration may result in spinal cord compression, leading to discomfort and mobility restrictions. Thammasen experienced this firsthand when her cancer spread to her spine, impairing her posture and causing subsequent foot pain. “Everything is kind of connected,” she points out, highlighting the intricate relationship between cancer and bodily function.
Dr. Billy Huh, a professor and medical director of pain medicine at the University of Texas MD Anderson Cancer Center, emphasises the severe implications of bone metastasis. He notes that weakened bone integrity can lead to fractures and intolerable pain due to nerve irritation. To combat her chronic pain, Thammasen relies on physical fitness; she has incorporated yoga into her routine, which has proven beneficial for her overall well-being.
For many cancer patients, treatment-related side effects can exacerbate physical pain. A 2024 study highlighted that a staggering 86% of metastatic breast cancer patients reported experiencing at least one significant side effect, resulting in some requiring emergency medical treatment. For instance, Sally Joy Wolf, diagnosed with early-stage breast cancer in 2015, developed hip pain following her chemotherapy regimen. A subsequent diagnosis revealed that her cancer had metastasised, leading to physical distress compounded by medication side effects. She ultimately underwent surgery to secure her femur, an experience that prompted her to adopt movement as a form of pain relief.
Wolf advocates for remaining active as a means of alleviating discomfort. Engaging in activities such as dancing and walking has been integral to her routine, allowing her to redefine her relationship with pain. Her tenacity is evident in her remarkable achievement of competing in the New York City Marathon just 17 months post-surgery.
When it comes to managing cancer-related pain, treatment options vary significantly among patients. Dr. Huh notes that long-acting opioids are commonly prescribed for chronic pain, though other interventions such as nerve injections or spinal cord stimulators may also provide relief. Chemotherapy, while effective in targeting cancer cells, can introduce collateral damage, resulting in neuropathy and other debilitating side effects. Consequently, individualised plans developed alongside healthcare providers are critical for managing these symptoms effectively.
The emotional toll of living with metastatic breast cancer is another crucial aspect of patient care that often goes overlooked. Thammasen speaks candidly about her struggles to engage in social activities that were once simple joys, such as cheering at her son’s softball games. “Everything revolves around my treatment, and it takes a lot of mental energy,” she reflects, acknowledging the need for personal reprioritisation amid her health challenges.
Dr. Huh emphasises the importance of addressing mental health, advocating for strategies that enable patients to coexist with their illness. He suggests fostering a mindset of acceptance, which can facilitate a more manageable and fulfilling life. Rather than striving for the elimination of cancer, patients are encouraged to seek a harmonious existence alongside it, engaging in what he characterises as a “peace treaty” with their condition.
In conclusion, as more individuals navigate the complexities of metastatic breast cancer, understanding and addressing both physical and emotional pain remain paramount. Ongoing research, effective treatment strategies, and support systems will be crucial in helping patients manage their symptoms and improve their overall quality of life.
